About
The company Daewoong Pharma is a South Korean company that operates in the pharmaceutical industry and specializes in the development, manufacturing, and distribution of innovative drugs. The company was founded in 1945 and is headquartered in Seoul. The beginnings of the company were rather humble, but over time, Daewoong Pharma developed into one of the leading companies in the Korean pharmaceutical industry. In 1982, the company was listed on the Korea Stock Exchange, attracting additional investors and customers. Since then, the company has evolved into a multinational corporation with operations and partners around the world. Daewoong Pharma's business model is focused on developing and selling innovative drugs. The company is involved in research, production, and distribution. Daewoong Pharma places great emphasis on prioritizing customer needs and providing them with tailored solutions. Daewoong Pharma offers a wide range of products, which can be divided into various categories. On one hand, they develop pharmaceutical products for the treatment of diseases such as diabetes, cancer, and cardiovascular diseases. On the other hand, the company also offers biotechnology products, as well as cosmetic and hygiene products. One example of an innovative product from Daewoong Pharma is the drug "Botulax", which is used for the treatment of wrinkles and spasms. It is a highly pure botulinum toxin produced through patented technology. Botulax is distributed in more than 50 countries worldwide and has become one of Daewoong Pharma's most successful products. Daewoong Pharma has also established partnerships with other companies and organizations to strengthen its presence in the global market. The company collaborates with various research institutes and universities to develop innovative drugs. Additionally, Daewoong Pharma has distribution partnerships with other pharmaceutical companies in Europe, Asia, and the USA. Overall, Daewoong Pharma has become a leading company in the South Korean pharmaceutical industry. The company stands out for its innovative research and production of drugs that are successfully distributed on the global market. Through its products and services, Daewoong Pharma contributes to improving the health of people worldwide.
Annual results
Reported figures, KRW · revenue up 10.4% in 2025
| Year | Revenue | Net income | Net margin | Free cash flow |
|---|---|---|---|---|
| 2025 | 1.6T | 196B | 12.5% | — |
| 2024 | 1.4T | 24.7B | 1.7% | — |
| 2023 | 1.4T | 122B | 8.9% | — |
| 2022 | 1.3T | 42.2B | 3.3% | — |
| 2021 | 1.2T | 24.7B | 2.1% | — |
Dividends per share
069620.KS in MarketPulse
The live chart with RSI and moving averages, the price, news, signals and price alerts for Daewoong Pharma are inside MarketPulse — currently in private beta.
Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.